Determinants of Antiretroviral Therapy Initiation and Treatment Outcomes for People Living With HIV in Vietnam

Tran, Dam Anh; Shakeshaft, Anthony; Ngo, Anh Duc; Mallitt, Kylie-Ann; Wilson, David; Doran, Christopher; Lei Zhang
January 2013
HIV Clinical Trials;Jan/Feb2013, Vol. 14 Issue 1, p21
Academic Journal
Objectives: This study explores patient characteristics that are significantly associated with very late combination antiretroviral therapy (cART) initiation (CD4 count ≤100 cells/mm³) and examines the association between patient characteristics and treatment outcomes, CD4 recovery, and mortality. Design: Data were obtained from the clinical records of 2,198 HIV/AIDS patients in 13 outpatient clinics across 6 provinces in Vietnam. Methods: Multivariate logistic regression and Cox proportional hazards regression were used to identify patient characteristics that are significantly associated with very late cART initiation and to measure relationships between patient characteristics and treatment outcomes. Results: Very late cART initiation was significantly associated with being male compared with female (odds ratio [OR], 0.36; 95% CI, 0.23-0.58), becoming HIV infected through injecting drugs (OR, 2.13; 95% CI, 1.09-4.14), and having opportunistic infections at cART initiation (OR, 1.69; 95% CI, 1.02-2.86). Being male (female vs male: hazard ratio [HR], 0.45; 95% CI, 0.20-0.98), very late cART initiation (timely vs late: HR, 0.18; 95% CI, 0.04-0.72), low baseline body mass index (BMI) (HR, 0.95; 95% CI, 0.92-0.98), and later baseline WHO clinical stage (WHO clinical stage IV vs combined group of stage I and II: HR, 5.70; 95% CI, 3.90-7.80) were significantly associated with death, whereas being female compared with male (HR, 1.51; 95% CI, 1.14-1.99) and timely cART initiation (HR, 35.45; 95% CI, 13.67-91.91) were significant predictors of CD4 recovery. Conclusions: Timely testing of patients for HIV, increasing use of CD4 count testing services, and starting cART earlier are essential to reduce mortality and improve treatment outcomes.


Related Articles

  • CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy. Peeling, Rosanna W.; Sollis, Kimberly A.; Glover, Sarah; Crowe, Suzanne M.; Landay, Alan L.; Cheng, Ben; Barnett, David; Denny, Thomas N.; Spira, Thomas J.; Stevens, Wendy S.; Crowley, Siobhan; Essajee, Shaffiq; Vitoria, Marco; Ford, Nathan // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: Measurement of CD4+ T-lymphocytes (CD4) is a crucial parameter in the management of HIV patients, particularly in determining eligibility to initiate antiretroviral treatment (ART). A number of technologies exist for CD4 enumeration, with considerable variation in cost, complexity,...

  • Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy. Leung, Victor; Gillis, Jennifer; Raboud, Janet; Cooper, Curtis; Hogg, Robert S.; Loutfy, Mona R.; Machouf, Nima; Montaner, Julio S. G.; Rourke, Sean B.; Tsoukas, Chris; Klein, Marina B. // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background: HIV leads to CD4:CD8 ratio inversion as immune dysregulation progresses. We examined the predictors of CD4:CD8 normalization after combination antiretroviral therapy (cART) and determined whether normalization is associated with reduced progression to AIDS-defining illnesses (ADI)...

  • When to Begin Highly Active Antiretroviral Therapy? Evidence Supporting Initiation of Therapy at CD4 + Lymphocyte Counts <350 cells/µµ L. Kaplan, Jonathan E.; Hanson, Debra L.; Cohn, David L.; Karon, John; Buskin, Susan; Thompson, Melanie; Fleming, Patricia; Dworkin, Mark S. // Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, p951 

    Assesses the risk of AIDS-related opportunistic illness or death among persons first prescribed highly active antiretroviral therapy in the U.S. Increase of HIV plasma RNA levels; Improvement of the quality of life of HIV-infected persons; Cause of the decrease of CD4[sup +] lymphocyte counts.

  • HAART-Persistent HIV-1 Latent Reservoirs: Their Origin, Mechanisms of Stability and Potential Strategies for Eradication. Kulkosky, Joseph; Bray, Stacie // Current HIV Research;Apr2006, Vol. 4 Issue 2, p199 

    HIV-1 infection persists despite long-term administration of highly active antiretroviral therapy (HAART). The mechanism of this persistence appears to result primarily from viral infection of CD4+ T-lymphocytes that have the ability to duplicate and revert into a quiescent state. These infected...

  • Étude pilote de la thérapie antirétrovirale à Djibouti. Ahmed, A. A.; Latoundji, S. // Eastern Mediterranean Health Journal;nov/dec2007, Vol. 13 Issue 6, p1274 

    A cross-sectional survey was conducted among 112 HIV positive patients who had received antiretroviral therapy for > 3 months to assess the efficacy of treatment (viral load < 400 copies/mL). The median age at enrolment was 36 years, 90% of patients were at the AIDS stage and median CD4 rate was...

  • CD8+ Cell Noncytotoxic Antiviral Response in Long-Term HIV-1 Infected Former Blood Donors in China. Lin Yuan; Liying Ma; Xiujuan Fan; Yi Feng; Hong Peng; Quanbi Zhao; Yuhua Ruan; Levy, J. A.; Yiming Shao // Current HIV Research;Jul2009, Vol. 7 Issue 4, p437 

    Most of the HIV-infected long term survivors show strong CD8+ cell noncytotoxic antiviral response (CNAR) that plays as an important factor for maintaining the relative healthy state of infected individuals. HIV infected former blood donors (FBDs) in Anhui, China are the unique population that...

  • CD4+ Count—Guided Interruption of Antiretroviral Treatment.  // New England Journal of Medicine;11/30/2006, Vol. 355 Issue 22, p2283 

    Background: Despite declines in morbidity and mortality with the use of combination antiretroviral therapy, its effectiveness is limited by adverse events, problems with adherence, and resistance of the human immunodeficiency virus (HIV). Methods: We randomly assigned persons infected with HIV...

  • Antivirograma, sensible, rápido y fácil de interpretar por un método de bioluminiscencia para el VIH-1. Lara, H. H.; Ixtepan-Turrent, L.; Rivera-Silva, G.; González-Salazar, F.; Moreno-Treviño, G. // Revista Latinoamericana de Patología Clínica y Medicina de Lab;abr-jun2013, Vol. 60 Issue 2, p79 

    Objective: To demonstrate that our assay is sensitive capable to detect 10 HIV infected cells per well and that is feasible to quantify HIV-1 resistance in seropositive patients. Method: To compare 3 different phenotypic assays by quantifying their sensitivities, first we co-cultivated...

  • Maintaining Patients on a Failing Antiretroviral Regimen Reduces the Risk of AIDS-defining Events. Winslow, Dean L. // Infectious Disease Alert;Mar2009, Vol. 28 Issue 6, p28 

    For this study, 12,765 patients from the large French Hospital Database for HIV with CD4+ lymphocyte counts < 200 cells/uL who received cART during 2000-2005 were selected. Three groups of patients were identified: patients who interrupted cART at least once, patients with detectable HIV RNA...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics